
Biora Therapeutics Inc
NASDAQ:BIOR

Intrinsic Value
The intrinsic value of one
BIOR
stock under the Base Case scenario is
5.81
USD.
Compared to the current market price of 0.22 USD,
Biora Therapeutics Inc
is
Undervalued by 96%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis
Want a deep‑dive on Biora Therapeutics Inc?
Request it below and we’ll move it up the queue.

Revenue & Expenses Breakdown
Biora Therapeutics Inc
Balance Sheet Decomposition
Biora Therapeutics Inc
Current Assets | 6.1m |
Cash & Short-Term Investments | 3.2m |
Receivables | 868k |
Other Current Assets | 2m |
Non-Current Assets | 8.5m |
PP&E | 2.2m |
Intangibles | 6.1m |
Other Non-Current Assets | 193k |
Free Cash Flow Analysis
Biora Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Biora Therapeutics Inc
Revenue
|
892k
USD
|
Operating Expenses
|
-61.8m
USD
|
Operating Income
|
-60.9m
USD
|
Other Expenses
|
29.3m
USD
|
Net Income
|
-31.5m
USD
|
BIOR Profitability Score
Profitability Due Diligence
Biora Therapeutics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Score
Biora Therapeutics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
BIOR Solvency Score
Solvency Due Diligence
Biora Therapeutics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Score
Biora Therapeutics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOR Price Targets Summary
Biora Therapeutics Inc
Dividends
Current shareholder yield for BIOR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?